A detailed history of Mariner, LLC transactions in Alvotech stock. As of the latest transaction made, Mariner, LLC holds 26,220 shares of ALVO stock, worth $334,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,220
Previous 27,104 3.26%
Holding current value
$334,305
Previous $331,000 3.93%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.4 - $14.51 $10,077 - $12,826
-884 Reduced 3.26%
26,220 $318,000
Q1 2024

May 15, 2024

SELL
$11.36 - $17.27 $11,257 - $17,114
-991 Reduced 3.53%
27,104 $331,000
Q4 2023

Feb 14, 2024

SELL
$8.55 - $11.48 $47,974 - $64,414
-5,611 Reduced 16.65%
28,095 $322,000
Q3 2023

Nov 13, 2023

BUY
$8.12 - $10.07 $61,265 - $75,978
7,545 Added 28.84%
33,706 $307,000
Q2 2023

Aug 11, 2023

BUY
$6.9 - $13.85 $49,590 - $99,539
7,187 Added 37.88%
26,161 $202,000
Q1 2023

May 12, 2023

BUY
$10.01 - $14.03 $189,929 - $266,205
18,974 New
18,974 $245,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.17B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.